Phosphodiesterase-5 inhibitors (PDE-5i) have been widely used as a treatment for erectile dysfunction (ED)1, despite originally developed as the treatment for pulmonary hypertension, ischemic heart disease, and altitude sickness2. This evidence concerns the gene ALDH7A1 and erectile dysfunction.